TRIGLYCERIDES

Back

CLINICAL SIGNIFICANCE
Triglyceride levels increase in hyperlipoproteinemias type I, IIb, III and V, in familial lack of lipoprotein lipase, in lack of lipoprotein lipase cofactor (Αpo C-ΙΙ), in familial dys-β-lipoproteinemia, familial combined hyperlipidemia, viral hepatitis, alcoholism, alcoholic cirrhosis, biliary cirrhosis, nephrotic syndrome, essential hypertension, diabetes mellitus, glycogen storage diseases type I, III and VI, thalassemia major, Down syndrome and various other endocrine diseases. Low triglyceride levels are observed in hypolipoproteinemia and a-β-lipoproteinemia, in hyperthyroidism, hyperparathyroidism, lactosuria, malnutrition, malabsorption syndrome, intestinal lymphangiectasia, end-stage liver parenchyma disease.
CHARACTERISTICS

Form: Liquid, ready-to-use
Shelf life: 24 months @ 2-8 C
On-Board Stability: 30 days
Sample: Serum or EDTA plasma
Detection limit: 1 mg/dL
Linearity: 4–1400 mg/dL


Packaging
For Use On
MEDILYZER
EX-OLYMPUS
GENERAL PURPOSE
SIEMENS ADVIA
Packaging
6x150 Tests
4x500 Tests
R1 2x100 mL, R2 2x25 mL & R1 4x125 mL
4x575 Tests